Doyeon Kim, Sangbin Han, You Sang Kim, Gyu‐Sung Choi, Jong Man Kim, Kyo Won Lee, Jae‐Hoon Ko, In Young Yoo, Justin Sangwook Ko, Mi Sook Gwak, Jae‐Won Joh, Gaab Soo Kim – 9 June 2022 – Bile duct surgeries are conventionally considered to promote bacterial contamination of the surgical field. However, liver transplantation recipients' bile produced by the newly implanted liver graft from healthy living donors may be sterile. We tested bacterial contamination of autologous blood salvaged before and after bile duct anastomosis (BDA) during living donor liver transplantation (LDLT).

C. Louwrens Braal, Robert J. Knegt, Agnes Jager, Stijn L. W. Koolen, Ron H. J. Mathijssen, Karel Eechoute – 9 June 2022 – Tamoxifen is a commonly prescribed drug in both early and metastatic breast cancer. Prospective studies in Asian populations demonstrated that tamoxifen‐related liver steatosis occurred in more than 30% of the patients within 2 years after start of treatment. No well‐designed prospective studies on potential tamoxifen‐related liver steatosis have been conducted in Caucasian patients so far.

Udeme D. Ekong, Sahithi Reddy, Nada Yazigi, Khalid Khan, Stuart Kaufman, Kimberly A. Chapman, Eyby Leon, Nicholas Ah Mew, Debra Regier, Erin MacLeod, Alexander Kroemer, Raffaelle Girlanda, Jason Hawksworth, Cal S. Matsumoto, Thomas M. Fishbein – 9 June 2022

Jun Xu, Ya Wang, Mina Khoshdeli, Matt Peach, Jen‐Chieh Chuang, Julie Lin, Wen‐Wei Tsai, Sangeetha Mahadevan, Wesley Minto, Lauri Diehl, Ruchi Gupta, Michael Trauner, Keyur Patel, Mazen Noureddin, Kris V. Kowdley, Aliya Gulamhusein, Christopher L. Bowlus, Ryan S. Huss, Robert P. Myers, Chuhan Chung, Andrew N. Billin – 9 June 2022

Anees Ahmad, Hamood Ur Rehman Chaudhry – 9 June 2022

8 June 2022

Zeinab Farhat, Neal D. Freedman, Joshua N. Sampson, Roni T. Falk, Jill Koshiol, Stephanie J. Weinstein, Demetrius Albanes, Rashmi Sinha, Erikka Loftfield – 7 June 2022 – Bile acids (BAs), major regulators of the gut microbiota, may play an important role in hepatobiliary cancer etiology. However, few epidemiologic studies have comprehensively examined associations between BAs and liver or biliary tract cancer.

AASLD develops evidence-based practice guidelines, practice guidances, and patient guidances  to share recommended approaches to the diagnostic, therapeutic, and preventive aspects of care.